Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis

Clinical trial NCT00470171 · COMPLETED

Trial details

NCT number: NCT00470171
Sponsor: Axcan Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Serum Levels of ALAT Transaminases Serum Markers for Fibrosis and Hepatic Inflammation

Start date: 2005-10-01
Primary completion: 2008-11-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.